{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:09:48Z","timestamp":1793419788834,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"DOI":"10.1186\/s12874-025-02486-5","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:12:10Z","timestamp":1738829530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Discrepancies in safety reporting for chronic back pain clinical trials: an observational study from ClinicalTrials.gov and publications"],"prefix":"10.1186","volume":"25","author":[{"given":"Nick","family":"Boyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Duke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Van Vleet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"issue":"4","key":"2486_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00296-019-04273-0","volume":"39","author":"F Fatoye","year":"2019","unstructured":"Fatoye F, Gebrye T, Odeyemi I. Real-world incidence and prevalence of low back pain using routinely collected data. Rheumatol Int. 2019;39(4):619\u201326. https:\/\/doi.org\/10.1007\/s00296-019-04273-0.","journal-title":"Rheumatol Int"},{"key":"2486_CR2","doi-asserted-by":"publisher","unstructured":"Fabricant PD, Heath MR, Schachne JM, Doyle SM, Green DW, Widmann RF. The epidemiology of back pain in American children and adolescents. Spine (Phila Pa 1976). 2020;45(16):1135\u20131142. https:\/\/doi.org\/10.1097\/BRS.0000000000003461","DOI":"10.1097\/BRS.0000000000003461"},{"issue":"7","key":"2486_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.7326\/0003-4819-147-7-200710020-00006","volume":"147","author":"R Chou","year":"2007","unstructured":"Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478\u201391. https:\/\/doi.org\/10.7326\/0003-4819-147-7-200710020-00006.","journal-title":"Ann Intern Med"},{"key":"2486_CR4","unstructured":"Finley CR, Chan DS, Garrison S, et al. What are the most common conditions in primary care? Systematic review. Can Fam Physician. 2018;64(11):832\u2013840. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6234945\/"},{"key":"2486_CR5","doi-asserted-by":"publisher","unstructured":"GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316-e329. https:\/\/doi.org\/10.1016\/S2665-9913(23)00098-X","DOI":"10.1016\/S2665-9913(23)00098-X"},{"issue":"7","key":"2486_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/M16-2367","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514\u201330. https:\/\/doi.org\/10.7326\/M16-2367.","journal-title":"Ann Intern Med"},{"key":"2486_CR7","doi-asserted-by":"publisher","unstructured":"Lanza FL, Chan FKL, Quigley EMM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728\u2013738. https:\/\/doi.org\/10.1038\/ajg.2009.115","DOI":"10.1038\/ajg.2009.115"},{"issue":"5","key":"2486_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s12325-023-02481-6","volume":"40","author":"JM LaForge","year":"2023","unstructured":"LaForge JM, Urso K, Day JM, et al. Non-steroidal anti-inflammatory drugs: Clinical implications, renal impairment risks, and AKI. Adv Ther. 2023;40(5):2082\u201396. https:\/\/doi.org\/10.1007\/s12325-023-02481-6.","journal-title":"Adv Ther"},{"key":"2486_CR9","unstructured":"Health and Human Services Department. Clinical Trials Registration and Results Information Submission. Federal Register. https:\/\/www.federalregister.gov\/documents\/2016\/09\/21\/2016-22129\/clinical-trials-registration-and-results-information-submission"},{"key":"2486_CR10","unstructured":"ClinicalTrials.gov to Include Basic Results Data. Published online October 21, 2008.\u00a0 https:\/\/www.nlm.nih.gov\/pubs\/techbull\/so08\/so08_clinicaltrials.html.\u00a0Accessed 23 Nov 2024."},{"key":"2486_CR11","unstructured":"Clinical Trials Registration and Results Information Submission. Federal Register. 2016;81(183):64981\u201365157.\u00a0https:\/\/www.federalregister.gov\/documents\/2016\/09\/21\/2016-22129\/clinical-trials-registration-and-results-information-submission. Accessed 27 Dec 2024."},{"key":"2486_CR12","unstructured":"Adverse Event Information. ClinicalTrials.gov.\u00a0https:\/\/clinicaltrials.gov\/policy\/results-definitions#adverseEventInformation. Accessed December 27, 2024."},{"issue":"5","key":"2486_CR13","doi-asserted-by":"publisher","first-page":"e0127495","DOI":"10.1371\/journal.pone.0127495","volume":"10","author":"PS Fleming","year":"2015","unstructured":"Fleming PS, Koletsi D, Dwan K, Pandis N. Outcome discrepancies and selective reporting: impacting the leading journals? PLoS ONE. 2015;10(5):e0127495. https:\/\/doi.org\/10.1371\/journal.pone.0127495.","journal-title":"PLoS ONE"},{"issue":"1","key":"2486_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s13063-019-3581-3","volume":"20","author":"E Mayo-Wilson","year":"2019","unstructured":"Mayo-Wilson E, Fusco N, Hong H, Li T, Canner JK, Dickersin K. Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events. Trials. 2019;20(1):553. https:\/\/doi.org\/10.1186\/s13063-019-3581-3.","journal-title":"Trials"},{"issue":"1","key":"2486_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13643-016-0289-2","volume":"5","author":"MJ Page","year":"2016","unstructured":"Page MJ, Higgins JPT. Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study. Syst Rev. 2016;5(1):108. https:\/\/doi.org\/10.1186\/s13643-016-0289-2.","journal-title":"Syst Rev"},{"issue":"1","key":"2486_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12916-020-01590-1","volume":"18","author":"S Cro","year":"2020","unstructured":"Cro S, Forbes G, Johnson NA, Kahan BC. Evidence of unexplained discrepancies between planned and conducted statistical analyses: a review of randomised trials. BMC Med. 2020;18(1):137. https:\/\/doi.org\/10.1186\/s12916-020-01590-1.","journal-title":"BMC Med"},{"issue":"7","key":"2486_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/M13-0480","volume":"160","author":"DM Hartung","year":"2014","unstructured":"Hartung DM, Zarin DA, Guise JM, McDonagh M, Paynter R, Helfand M. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med. 2014;160(7):477\u201383. https:\/\/doi.org\/10.7326\/M13-0480.","journal-title":"Ann Intern Med."},{"key":"2486_CR18","doi-asserted-by":"publisher","unstructured":"Saini P, Loke YK, Gamble C, Altman DG, Williamson PR, Kirkham JJ. Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews.\u00a0BMJ. 2014;349:g6501. Published 2014 Nov 21. https:\/\/doi.org\/10.1136\/bmj.g6501","DOI":"10.1136\/bmj.g6501"},{"key":"2486_CR19","unstructured":"Accessed November 23, 2024. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5370619\/"},{"key":"2486_CR20","doi-asserted-by":"crossref","unstructured":"Accessed November 23, 2024. https:\/\/osf.io\/596rh\/","DOI":"10.32964\/TJ23.11"},{"key":"2486_CR21","unstructured":"Journal Citation Reports. Academia and Government. July 16, 2024.\u00a0 https:\/\/clarivate.com\/academia-government\/scientific-and-academic-research\/research-funding-analytics\/journal-citation-reports\/ .\u00a0Accessed 23 Nov 2024."},{"issue":"1","key":"2486_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12874-022-01730-6","volume":"22","author":"I Paladin","year":"2022","unstructured":"Paladin I, Prani\u0107 SM. Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: An observational study. BMC Med Res Methodol. 2022;22(1):262. https:\/\/doi.org\/10.1186\/s12874-022-01730-6.","journal-title":"BMC Med Res Methodol."},{"issue":"6","key":"2486_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bcpt.13791","volume":"131","author":"T Westergren","year":"2022","unstructured":"Westergren T, Narum S, Klemp M. Biases in reporting of adverse effects in clinical trials, and potential impact on safety assessments in systematic reviews and therapy guidelines. Basic Clin Pharmacol Toxicol. 2022;131(6):465\u201373. https:\/\/doi.org\/10.1111\/bcpt.13791.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"8","key":"2486_CR24","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/jnci\/djab015","volume":"113","author":"ZW Veitch","year":"2021","unstructured":"Veitch ZW, Shepshelovich D, Gallagher C, Wang L, Abdul Razak AR, Spreafico A, Bedard PL, Siu LL, Minasian L, Hansen AR. Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials. JNCI J Natl Cancer Inst. 2021;113(8):980\u20138. https:\/\/doi.org\/10.1093\/jnci\/djab015.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"10","key":"2486_CR25","doi-asserted-by":"publisher","first-page":"e1001526","DOI":"10.1371\/journal.pmed.1001526","volume":"10","author":"B Wieseler","year":"2013","unstructured":"Wieseler B, McGauran N, Kerekes MF, et al. Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data. PLoS Med. 2013;10(10):e1001526. https:\/\/doi.org\/10.1371\/journal.pmed.1001526.","journal-title":"PLoS Med"},{"issue":"9","key":"2486_CR26","doi-asserted-by":"publisher","first-page":"e1002127","DOI":"10.1371\/journal.pmed.10021272","volume":"13","author":"S Golder","year":"2016","unstructured":"Golder S, Loke YK, Wright K, Norman G. Reporting of adverse events in published and unpublished studies of health care interventions: a systematic review. PLoS Med. 2016;13(9):e1002127. https:\/\/doi.org\/10.1371\/journal.pmed.10021272.","journal-title":"PLoS Med"},{"issue":"6","key":"2486_CR27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamadermatol.2015.36","volume":"151","author":"SM Belknap","year":"2015","unstructured":"Belknap SM, Aslam I, Kiguradze T, et al. Adverse event reporting in clinical trials of finasteride for androgenic alopecia: A meta-analysis: A meta-analysis. JAMA Dermatol. 2015;151(6):600\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2015.36.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"2486_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1200\/JCO.2013.52.2219","volume":"32","author":"S Sivendran","year":"2014","unstructured":"Sivendran S, Latif A, McBride RB, et al. Adverse event reporting in cancer clinical trial publications. J Clin Oncol. 2014;32(2):83\u20139. https:\/\/doi.org\/10.1200\/JCO.2013.52.2219.","journal-title":"J Clin Oncol"},{"key":"2486_CR29","unstructured":"Licorn Publishing. Servier \u2013 Phlebolymphology. Servier - Phlebolymphology. September 8, 2022. https:\/\/www.phlebolymphology.org\/cyanoacrylate-closure-in-the-treatment-of-varicose-veins-what-is-the-evidence\/.\u00a0Accessed 23 Nov 2024."},{"issue":"2","key":"2486_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/02683555231211086","volume":"39","author":"K Parsi","year":"2024","unstructured":"Parsi K, Zhang L, Whiteley MS, et al. 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure. Phlebology. 2024;39(2):80\u201395. https:\/\/doi.org\/10.1177\/02683555231211086.","journal-title":"Phlebology"},{"key":"2486_CR31","doi-asserted-by":"publisher","first-page":"e073725","DOI":"10.1136\/bmj-2022-073725","volume":"381","author":"DR Junqueira","year":"2023","unstructured":"Junqueira DR, Zorzela L, Golder S, et al. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials. BMJ. 2023;381:e073725. https:\/\/doi.org\/10.1136\/bmj-2022-073725.","journal-title":"BMJ"},{"issue":"11","key":"2486_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jpain.2016.07.006","volume":"17","author":"MR Williams","year":"2016","unstructured":"Williams MR, McKeown A, Pressman Z, et al. Adverse event reporting in clinical trials of intravenous and invasive pain treatments: An ACTTION systematic review. J Pain. 2016;17(11):1137\u201349. https:\/\/doi.org\/10.1016\/j.jpain.2016.07.006.","journal-title":"J Pain"},{"issue":"31","key":"2486_CR33","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1200\/JCO.2013.49.3981","volume":"31","author":"J P\u00e9ron","year":"2013","unstructured":"P\u00e9ron J, Maillet D, Gan HK, Chen EX, You B. Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. J Clin Oncol. 2013;31(31):3957\u201363. https:\/\/doi.org\/10.1200\/JCO.2013.49.3981.","journal-title":"J Clin Oncol"},{"key":"2486_CR34","doi-asserted-by":"crossref","unstructured":"Hammad TA, Afsar S, Le-Louet H, et al. Navigating a transforming landscape: the evolving role of pharmacovigilance physicians in drug development and implications for future challenges and training.\u00a0Front Drug SafetyRegul.\u00a02023. Available at:\u00a0https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2023.1257732\/full. Accessed 27 Dec 2024.","DOI":"10.3389\/fdsfr.2023.1257732"},{"key":"2486_CR35","doi-asserted-by":"crossref","unstructured":"Tang H, Solti I, Kirkendall E, Zhai H, Solti I. Leveraging FDA adverse event reports for the automated monitoring of electronic health records in a pediatric hospital.\u00a0SAGE Open Medicine. 2017;1178222617713018. Available at: https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1178222617713018\n. Accessed 27 Dec 2024.","DOI":"10.1177\/1178222617713018"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02486-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-025-02486-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02486-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:12:16Z","timestamp":1738829536000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-025-02486-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1186\/s12874-025-02486-5","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Oklahoma State University Center for Health Sciences Institutional Review Board reviewed the study protocol and determined that the research qualifies as nonhuman subjects research, in accordance with 45 CFR 46.102(d) and (f).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}